Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel vs Capecitabine in First-line Advanced Breast Cancer
NCT01609127Phase 2Unknown
- Sponsor
- Genta Incorporated
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tesetaxel in breast cancer, sponsored by Genta Incorporated. Status: unknown.
02
Drugs
tesetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01609127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609127.